TR200101719T2 - Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı - Google Patents
Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımıInfo
- Publication number
- TR200101719T2 TR200101719T2 TR2001/01719T TR200101719T TR200101719T2 TR 200101719 T2 TR200101719 T2 TR 200101719T2 TR 2001/01719 T TR2001/01719 T TR 2001/01719T TR 200101719 T TR200101719 T TR 200101719T TR 200101719 T2 TR200101719 T2 TR 200101719T2
- Authority
- TR
- Turkey
- Prior art keywords
- treatment
- erectile dysfunction
- apomorphine
- men
- drug manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Bulus erkeklerde organik ereksiyona bagli islev bozuklugunun, özellikle vaskülojenik ereksiyona bagli islev bozuklugunun, apomorfin veya bunun farmasötik olarak kabul edilebilir tuzu, esteri veya ecza hazirlik maddesinin terapötik olarak etkili miktarinin, bu gibi bir tedavi gereksiniminde olan erkege uygulanmasini içeren bir yöntemle tedavi edilmesi ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/213,567 US6291471B1 (en) | 1998-12-17 | 1998-12-17 | Use of apomorphine for the treatment of organic erectile dysfunction in males |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101719T2 true TR200101719T2 (tr) | 2002-08-21 |
Family
ID=22795606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01719T TR200101719T2 (tr) | 1998-12-17 | 1999-12-13 | Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı |
Country Status (22)
Country | Link |
---|---|
US (1) | US6291471B1 (tr) |
EP (1) | EP1140094A1 (tr) |
JP (1) | JP2003521462A (tr) |
KR (1) | KR20010101241A (tr) |
CN (1) | CN1335772A (tr) |
AR (1) | AR021912A1 (tr) |
AU (1) | AU2175800A (tr) |
BG (1) | BG105664A (tr) |
BR (1) | BR9916114A (tr) |
CA (1) | CA2354601A1 (tr) |
CZ (1) | CZ20012084A3 (tr) |
HK (1) | HK1043303A1 (tr) |
HU (1) | HUP0201618A3 (tr) |
IL (1) | IL143410A0 (tr) |
NO (1) | NO20012985L (tr) |
NZ (1) | NZ511790A (tr) |
PL (1) | PL354920A1 (tr) |
SK (1) | SK8262001A3 (tr) |
TR (1) | TR200101719T2 (tr) |
TW (1) | TW577740B (tr) |
WO (1) | WO2000035457A1 (tr) |
ZA (1) | ZA200104146B (tr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6566368B2 (en) * | 1994-04-22 | 2003-05-20 | Pentech Pharmaceuticals, Inc. | Apomorphine-containing dosage form for ameliorating male erectile dysfunction |
BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
ATE358483T1 (de) * | 2000-11-22 | 2007-04-15 | Abbott Lab | Selektive dopamin-d4-rezeptoragonisten zur behandlung von sexuellen dysfunktionen |
WO2002062315A1 (en) * | 2001-02-08 | 2002-08-15 | Pharmacia Corporation | Rapid-onset medicament for the treatment of sexual dysfunction |
AU2003223304A1 (en) * | 2002-03-19 | 2003-10-08 | Michael Holick | Glycoside and orthoester glycoside derivatives of apomorphine, analogs, and uses thereof |
SE0202365D0 (sv) | 2002-08-05 | 2002-08-05 | Pharmacia Ab | New formulation and use thereof |
US20040204439A1 (en) * | 2003-04-14 | 2004-10-14 | Staniforth John Nicholas | Composition, device, and method for treating sexual dysfunction via inhalation |
BRPI0409380A (pt) * | 2003-04-14 | 2006-04-18 | Vectura Ltd | composições farmacêuticas |
CA2562465A1 (en) * | 2004-04-13 | 2005-10-27 | The Mclean Hospital Corporation | R(-)-11-hydroxyaporphine derivatives and uses thereof |
GB2437488A (en) * | 2006-04-25 | 2007-10-31 | Optinose As | Pharmaceutical oily formulation for nasal or buccal administration |
WO2009009083A1 (en) * | 2007-07-12 | 2009-01-15 | The Mclean Hospital Corporation | R(-)-2-methoxy-11-hydroxyaporphine and derivatives thereof |
BRPI0800596A2 (pt) | 2008-01-31 | 2009-09-22 | Univ Minas Gerais | método para a potencialização da função erétil através do uso das composições farmacêuticas de toxina tx2-6 da aranha phoneutria nigriventer |
AU2011343429B2 (en) | 2010-12-16 | 2016-10-20 | Sunovion Pharmaceuticals Inc. | Sublingual films |
KR101374500B1 (ko) * | 2012-10-09 | 2014-03-13 | 울산대학교 산학협력단 | R(-)-프로필노르아포모르핀을 유효성분으로 포함하는 암의 예방 또는 치료용 약학 조성물 |
ES2702174T3 (es) | 2013-04-05 | 2019-02-27 | Boehringer Ingelheim Int | Usos terapéuticos de empagliflozina |
US20140303097A1 (en) | 2013-04-05 | 2014-10-09 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
US11813275B2 (en) | 2013-04-05 | 2023-11-14 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition, methods for treating and uses thereof |
PT2986304T (pt) | 2013-04-18 | 2022-02-25 | Boehringer Ingelheim Int | Composição farmacêutica, métodos para o tratamento e suas utilizações |
EP3288561B1 (en) * | 2015-04-30 | 2021-03-31 | Boehringer Ingelheim International GmbH | Methods and pharmaceutical compositions comprising a sglt2 inhibitor for treating or improving erectile dysfunction |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
JP2021527875A (ja) * | 2018-06-14 | 2021-10-14 | アストラゼネカ・ユーケイ・リミテッドAstraZeneca UK Limited | Cgmp特異的ホスホジエステラーゼ5阻害剤の薬学的組成物により***不全を治療するための方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256652A (en) | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
US5270323A (en) | 1990-05-31 | 1993-12-14 | Pfizer Inc. | Method of treating impotence |
US5292520A (en) | 1990-09-13 | 1994-03-08 | Akzo N.V. | Stabilized solid pharmaceutical composition containing acid addition salts of a basic drug and an alkaline stabilizer |
ATE290864T1 (de) | 1993-03-26 | 2005-04-15 | Franciscus Wilhelmus He Merkus | Pharmazeutische zusammensetzungen zur intranasalen verabreichung von dihydroergotamin |
DE69514794T2 (de) * | 1994-04-22 | 2000-07-27 | Pentech Pharmaceuticals Inc | Sublinguale dosierungsformen enthaltend apomorphin zur verwendung bei der behandlung von erektiler dysfunktion |
US5562917A (en) | 1994-12-23 | 1996-10-08 | Pentech Pharmaceuticals, Inc. | Transdermal administration of apomorphine |
US5888534A (en) | 1995-06-13 | 1999-03-30 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5624677A (en) * | 1995-06-13 | 1997-04-29 | Pentech Pharmaceuticals, Inc. | Controlled release of drugs delivered by sublingual or buccal administration |
US5688499A (en) | 1996-03-13 | 1997-11-18 | Queen's University At Kingston | Antagonism of endothelin actions |
DE19652268C2 (de) | 1996-12-16 | 2000-06-29 | Lohmann Therapie Syst Lts | Arzneizubereitung für die Freisetzung von Apomorphin in der Mundhöhle |
-
1998
- 1998-12-17 US US09/213,567 patent/US6291471B1/en not_active Expired - Fee Related
-
1999
- 1999-12-13 JP JP2000587777A patent/JP2003521462A/ja not_active Withdrawn
- 1999-12-13 IL IL14341099A patent/IL143410A0/xx unknown
- 1999-12-13 CN CN99814559A patent/CN1335772A/zh active Pending
- 1999-12-13 WO PCT/US1999/029449 patent/WO2000035457A1/en not_active Application Discontinuation
- 1999-12-13 BR BR9916114-1A patent/BR9916114A/pt not_active IP Right Cessation
- 1999-12-13 AU AU21758/00A patent/AU2175800A/en not_active Abandoned
- 1999-12-13 CZ CZ20012084A patent/CZ20012084A3/cs unknown
- 1999-12-13 CA CA002354601A patent/CA2354601A1/en not_active Abandoned
- 1999-12-13 PL PL99354920A patent/PL354920A1/xx not_active Application Discontinuation
- 1999-12-13 KR KR1020017007500A patent/KR20010101241A/ko not_active Application Discontinuation
- 1999-12-13 TR TR2001/01719T patent/TR200101719T2/tr unknown
- 1999-12-13 EP EP99966147A patent/EP1140094A1/en not_active Withdrawn
- 1999-12-13 HU HU0201618A patent/HUP0201618A3/hu unknown
- 1999-12-13 NZ NZ511790A patent/NZ511790A/en unknown
- 1999-12-13 SK SK826-2001A patent/SK8262001A3/sk unknown
- 1999-12-17 AR ARP990106551A patent/AR021912A1/es not_active Application Discontinuation
-
2000
- 2000-01-11 TW TW088122257A patent/TW577740B/zh not_active IP Right Cessation
-
2001
- 2001-05-21 ZA ZA200104146A patent/ZA200104146B/xx unknown
- 2001-06-15 NO NO20012985A patent/NO20012985L/no not_active Application Discontinuation
- 2001-07-03 BG BG105664A patent/BG105664A/xx unknown
-
2002
- 2002-03-28 HK HK02102415.1A patent/HK1043303A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
HUP0201618A2 (en) | 2002-09-28 |
CZ20012084A3 (cs) | 2002-01-16 |
NZ511790A (en) | 2004-04-30 |
ZA200104146B (en) | 2002-08-21 |
CN1335772A (zh) | 2002-02-13 |
EP1140094A1 (en) | 2001-10-10 |
HUP0201618A3 (en) | 2003-03-28 |
JP2003521462A (ja) | 2003-07-15 |
WO2000035457A1 (en) | 2000-06-22 |
HK1043303A1 (zh) | 2002-09-13 |
IL143410A0 (en) | 2002-04-21 |
US6291471B1 (en) | 2001-09-18 |
AR021912A1 (es) | 2002-09-04 |
AU2175800A (en) | 2000-07-03 |
PL354920A1 (en) | 2004-03-22 |
BG105664A (en) | 2002-02-28 |
CA2354601A1 (en) | 2000-06-22 |
NO20012985L (no) | 2001-08-16 |
NO20012985D0 (no) | 2001-06-15 |
TW577740B (en) | 2004-03-01 |
BR9916114A (pt) | 2003-01-14 |
SK8262001A3 (en) | 2002-01-07 |
KR20010101241A (ko) | 2001-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200101719T2 (tr) | Erkeklerde organik ereksiyona bağlı işlev bozukluğunun tedavisi için ilaç imalatında apomorfin kullanımı | |
DK1161248T3 (da) | Farmaceutisk sammensætning indeholdende en nitratkilde og et forsurende middel til behandling af åbne sår og forbrændinger | |
HK1065483A1 (en) | 4-amino-6-phenyl-pyrrolo[2,3-d]pyrimidine derivatives | |
HUP0101268A2 (hu) | A női nemi diszfunkció kezelésére alkalmas gyógyszerkészítmények | |
HUP0300590A2 (hu) | Peptidázzal hasítható, célzott antineoplasztikus szerek és terápiás alkalmazásuk | |
ATE464049T1 (de) | Pharmazeutische kombinationen von hydrocodon und naltrexon | |
PA8479201A1 (es) | Derivados del acido hidroxi-pipecolato hidroxamico | |
GB2431346C (en) | A combination composition comprising paracetamol and ibuprofen | |
BR0305628A (pt) | Composição farmacêutica para tratar disfunção sexual num mamìfero compreendendo peptìdeo e seu uso | |
EA200901393A1 (ru) | Фармацевтическая композиция, содержащая гестагены и/или эстрогены и 5 метил-(6s)-тетрагидрофолат | |
TW200509949A (en) | Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents | |
SE0102440D0 (sv) | New compound | |
DK1225902T3 (da) | Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden | |
ATE319473T1 (de) | Melagatran zur behandlung von entzündungen | |
HUP0100171A2 (hu) | Endotelin-receptor-antagonisták alkalmazása elhízás leküzdésére szolgáló gyógyszerkészítmények előállítására | |
EE200300129A (et) | Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine | |
UY26171A1 (es) | Método y formulación farmacéutica para el tratamiento de la discinesia de aparición tardía | |
BRPI0507811A (pt) | derivados de 7h-pirrolopirimidina | |
EP1626731A4 (en) | ANTI-INFLAMMATORY MEDICINE PREPARATIONS FOR INFLAMMATORY INFLAMMATION AND THE THERAPY OR PROPHYLAXIS OF GASTRIC TOXICITY | |
EE200100066A (et) | Naatriumkloriidi kasutamine kamptotetsiini derivaatide manustamisest tingitud gastrointestinaalsetekõrvaltoimete vähendamiseks | |
AR034142A1 (es) | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion | |
YU87501A (sh) | Farmaceutski kompleksi | |
HUP9901659A2 (hu) | Flupirtin alkalmazása a hematopoetikus sejtrendszer károsodásával kapcsolatos megbetegedések megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására | |
SE0000303D0 (sv) | Novel compounds | |
ATE250076T1 (de) | 6-o-carbamat ketolide derivate |